With a revenue increase of 34.55% in the first quarter 2024, year on year to cumulative value of $175 million, Deciphera Pharmaceuticals Inc 's revenue per employee grew on a trailing twelve months basis to $ 492,704. The productivity of Deciphera Pharmaceuticals Inc 's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 63 other companies have achieved higher revenue per employee. While Deciphera Pharmaceuticals Inc 's total ranking has deteriorated compared to the previous quarter from 122 to 743. Deciphera Pharmaceuticals Inc has 355 employees.

What is Sales per Employee Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Revenue per Employee▼

None ▼

Revenue per Employee▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

DCPH Revenue per Employee	(Mar 31 2024) I. Quarter	(Dec 31 2023) IV. Quarter	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter
Y / Y Revenue Change	34.55 %	32.88 %	20.4 %	17.88 %	14.45 %
Sales per Employee (TTM) $	492,704	460,158	426,499	405,825	389,459
DCPH's Total Ranking	# 743	# 122	# 224	# 1275	# 1341
Seq. Revenue Change	-6.82 %	11.5 %	13.08 %	14.53 %	-7.98 %

DCPH Company Profile >> Back to DCPH Efficiency Comparisons >> Compare DCPH Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 35
Healthcare Sector	# 64
Overall Market	# 743

Revenue per Employee Statistics
High	Average	Low
$ 607,326	$ 376,744	$ 0
(Mar 31 2024)		(Sep 30 2020)

Financial Statements
Deciphera Pharmaceuticals Inc 's Revenue MRQ	$ 45 Millions	Visit DCPH's Income Statement
Deciphera Pharmaceuticals Inc 's Revenues TTM	$ 175 Millions	Visit DCPH's aggregate revenue growth
What are DCPH's Sales?		Visit DCPH's Sales by Segment

Other Ratios
Deciphera Pharmaceuticals Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
DCPH's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for DCPH's Competitors
Revenue per Employee for DCPH's Suppliers
Revenue per Employee for DCPH's Customers

You may also want to know
DCPH's Sales Growth Rates	DCPH's Pe Price to earnings ratio	DCPH's Receivables Turnover Ratio	DCPH's Stock Quote
DCPH's Net Income Growth Rates	DCPH's Ps Price to Sales ratio	DCPH's Sales per Employee	DCPH's Asset Turnover Ratio
DCPH's Net Margin	DCPH's Pb Price to Book ratio	DCPH's Financial Strength Ratios	DCPH's Dividend Payout Ratio

Date modified: 2026-08-29T17:38:25+00:00

Companies with similar Revenue per Employee for 12 months ending Mar 31 2024, within Healthcare Sector	Revenue per Employee	Revenue 12 months ending Mar 31 2024	Number of Employees Mar 31 2024
Dynavax Technologies Corporation	855,087.27	$ 235.149 Million	275
Regeneron Pharmaceuticals Inc	850,103.83	$ 13,100.100 Million	15,410
Carlisle Companies Incorporated	849,101.69	$ 5,009.700 Million	5,900
Precision Biosciences Inc	846,044.12	$ 57.531 Million	68
Y mabs Therapeutics inc	844,990.00	$ 84.499 Million	100
Voyager Therapeutics Inc	844,283.69	$ 119.044 Million	141
Alkermes Plc	842,040.00	$ 1,726.182 Million	2,050
Amicus Therapeutics inc	825,561.64	$ 421.862 Million	511
Kiniksa Pharmaceuticals International Plc	824,513.66	$ 301.772 Million	366
Pacira Biosciences inc	822,381.18	$ 681.754 Million	829
Merck and Co Inc	818,706.67	$ 61,403.000 Million	75,000
Biocryst Pharmaceuticals Inc	817,000.00	$ 355.395 Million	435
Alnylam Pharmaceuticals Inc	801,334.00	$ 2,003.335 Million	2,500
Editas Medicine Inc	797,781.61	$ 69.407 Million	87
Esperion Therapeutics Inc	781,428.57	$ 229.740 Million	294
Biomarin Pharmaceutical Inc	767,353.00	$ 2,471.644 Million	3,221
Verve Therapeutics Inc	764,238.10	$ 16.049 Million	21
Evoke Pharma Inc	763,214.00	$ 6.106 Million	8
Emmaus Life Sciences Inc	757,818.18	$ 25.008 Million	33
Eton Pharmaceuticals Inc	744,636.36	$ 32.764 Million	44
Pfizer Inc	734,573.33	$ 55,093.000 Million	75,000
Tg Therapeutics Inc	725,145.36	$ 289.333 Million	399
Eli Lilly And Company	718,642.00	$ 35,932.100 Million	50,000
Corcept Therapeutics Inc	717,163.01	$ 523.529 Million	730
Ati Physical Therapy Inc	713,556.00	$ 713.556 Million	1,000
Apellis Pharmaceuticals Inc	709,161.03	$ 524.070 Million	739
Beam Therapeutics Inc	706,283.76	$ 360.911 Million	511
Rigel Pharmaceuticals Inc	691,643.68	$ 120.346 Million	174
Arbutus Biopharma Corp	683,473.68	$ 12.986 Million	19
Theravance Biopharma inc	683,444.44	$ 61.510 Million	90

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.